Trial
NCT04844073
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Squamous Cell Cancer of Head and Neck (SCCHN)
Intervention
TAK-186
Why stopped
Sponsor decision based on limited anti-cancer activity of TAK-186.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-04